Efforts needed to de-escalate use of inhaled corticosteroids in COPD

Respiratory specialist cautions against overuse of ICS in primary care

Inhaled corticosteroids (ICS) are widely used in chronic obstructive pulmonary disease (COPD) though their effectiveness is only proven in patients with certain phenotypes and remains controversial in others.

Sydney respiratory physician Dr Deborah Yates says overuse of ICS is “very common” in Australia sometimes resulting in undesirable consequences in patients with COPD.